版本:
中国

BRIEF-Invitae Corp announces a program in partnership with Alnylam Pharmaceuticals

April 3 Alnylam Pharmaceuticals Inc

* Announced a program in partnership with Alnylam Pharmaceuticals to provide genetic testing for hereditary ATTR (HATTR) amyloidosis Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐